

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GMP metabolic process (GO:0046037) | 9.71676447 |
| 2 | * visual perception (GO:0007601) | 8.80004841 |
| 3 | * sensory perception of light stimulus (GO:0050953) | 8.70208576 |
| 4 | retinal rod cell development (GO:0046548) | 8.51516219 |
| 5 | * cellular response to light stimulus (GO:0071482) | 7.30704557 |
| 6 | regulation of cGMP metabolic process (GO:0030823) | 7.17111268 |
| 7 | eye photoreceptor cell differentiation (GO:0001754) | 7.14046213 |
| 8 | photoreceptor cell differentiation (GO:0046530) | 7.14046213 |
| 9 | * detection of external stimulus (GO:0009581) | 7.12038538 |
| 10 | * detection of abiotic stimulus (GO:0009582) | 6.99062038 |
| 11 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 6.80830575 |
| 12 | positive regulation of cGMP biosynthetic process (GO:0030828) | 6.78769870 |
| 13 | retina development in camera-type eye (GO:0060041) | 6.56329181 |
| 14 | cell wall macromolecule metabolic process (GO:0044036) | 6.54740848 |
| 15 | regulation of cGMP biosynthetic process (GO:0030826) | 6.40237658 |
| 16 | positive regulation of cGMP metabolic process (GO:0030825) | 5.99955906 |
| 17 | positive regulation of chemokine secretion (GO:0090197) | 5.80619579 |
| 18 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.44445706 |
| 19 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 5.41209168 |
| 20 | glucosamine-containing compound catabolic process (GO:1901072) | 5.30777547 |
| 21 | regulation of chemokine secretion (GO:0090196) | 5.18804454 |
| 22 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 5.13577235 |
| 23 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 4.98865915 |
| 24 | nonmotile primary cilium assembly (GO:0035058) | 4.97474565 |
| 25 | * cellular response to radiation (GO:0071478) | 4.76023206 |
| 26 | positive regulation of B cell differentiation (GO:0045579) | 4.74507367 |
| 27 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.62975141 |
| 28 | adaptation of signaling pathway (GO:0023058) | 4.35941266 |
| 29 | * regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 4.25662021 |
| 30 | short-term memory (GO:0007614) | 4.25120899 |
| 31 | regulation of voltage-gated calcium channel activity (GO:1901385) | 4.14503463 |
| 32 | * sensory perception (GO:0007600) | 4.12932113 |
| 33 | regulation of penile erection (GO:0060405) | 4.00950946 |
| 34 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.98319813 |
| 35 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.95768933 |
| 36 | immunoglobulin mediated immune response (GO:0016064) | 3.94190437 |
| 37 | * response to light stimulus (GO:0009416) | 3.88446489 |
| 38 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.86590937 |
| 39 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.86590937 |
| 40 | behavioral response to ethanol (GO:0048149) | 3.84643372 |
| 41 | protein prenylation (GO:0018342) | 3.83108484 |
| 42 | prenylation (GO:0097354) | 3.83108484 |
| 43 | Peyers patch development (GO:0048541) | 3.79313095 |
| 44 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.79313095 |
| 45 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.78929707 |
| 46 | estrogen biosynthetic process (GO:0006703) | 3.78374451 |
| 47 | amino sugar catabolic process (GO:0046348) | 3.77729725 |
| 48 | chemosensory behavior (GO:0007635) | 3.75805639 |
| 49 | positive thymic T cell selection (GO:0045059) | 3.75137772 |
| 50 | negative T cell selection (GO:0043383) | 3.72788064 |
| 51 | neuron development (GO:0048666) | 3.66270534 |
| 52 | negative thymic T cell selection (GO:0045060) | 3.63796177 |
| 53 | retina homeostasis (GO:0001895) | 3.62236907 |
| 54 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.61369019 |
| 55 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 3.61182193 |
| 56 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.59261757 |
| 57 | negative regulation of cell killing (GO:0031342) | 3.59261757 |
| 58 | retina layer formation (GO:0010842) | 3.58623628 |
| 59 | DNA deamination (GO:0045006) | 3.55161830 |
| 60 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.53778048 |
| 61 | positive regulation of prostaglandin secretion (GO:0032308) | 3.53012866 |
| 62 | response to histamine (GO:0034776) | 3.51948891 |
| 63 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.48481108 |
| 64 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.42818322 |
| 65 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.41641407 |
| 66 | deoxyribonucleotide catabolic process (GO:0009264) | 3.33778879 |
| 67 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.33527184 |
| 68 | regulation of B cell differentiation (GO:0045577) | 3.33506438 |
| 69 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.30375501 |
| 70 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.30041569 |
| 71 | response to interferon-beta (GO:0035456) | 3.29761302 |
| 72 | vitamin A metabolic process (GO:0006776) | 3.28207755 |
| 73 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.26664458 |
| 74 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.24987716 |
| 75 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.24018279 |
| 76 | B cell mediated immunity (GO:0019724) | 3.23015606 |
| 77 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.20166653 |
| 78 | purine nucleotide salvage (GO:0032261) | 3.17974349 |
| 79 | positive regulation of neurotransmitter transport (GO:0051590) | 3.17371294 |
| 80 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.14843150 |
| 81 | negative regulation of B cell apoptotic process (GO:0002903) | 3.14729020 |
| 82 | ribosomal small subunit assembly (GO:0000028) | 3.13313543 |
| 83 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.12130145 |
| 84 | positive T cell selection (GO:0043368) | 3.11071786 |
| 85 | deoxyribose phosphate catabolic process (GO:0046386) | 3.10107915 |
| 86 | retinoid metabolic process (GO:0001523) | 3.08581743 |
| 87 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.07030535 |
| 88 | positive regulation of interleukin-17 production (GO:0032740) | 3.03073322 |
| 89 | mast cell activation (GO:0045576) | 3.02581304 |
| 90 | regulation of B cell apoptotic process (GO:0002902) | 2.99102753 |
| 91 | regulation of gamma-delta T cell activation (GO:0046643) | 2.98862600 |
| 92 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.95105185 |
| 93 | membrane hyperpolarization (GO:0060081) | 2.93772954 |
| 94 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.93504309 |
| 95 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.93129341 |
| 96 | positive regulation of T cell cytokine production (GO:0002726) | 2.93129121 |
| 97 | icosanoid secretion (GO:0032309) | 2.90854732 |
| 98 | arachidonic acid secretion (GO:0050482) | 2.90854732 |
| 99 | negative regulation of T cell apoptotic process (GO:0070233) | 2.88621235 |
| 100 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.87987185 |
| 101 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.87447770 |
| 102 | protein heterotetramerization (GO:0051290) | 2.86925150 |
| 103 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.86497404 |
| 104 | diterpenoid metabolic process (GO:0016101) | 2.84617300 |
| 105 | response to peptidoglycan (GO:0032494) | 2.83683353 |
| 106 | synaptic transmission, dopaminergic (GO:0001963) | 2.83354986 |
| 107 | regulation of prostaglandin secretion (GO:0032306) | 2.83148436 |
| 108 | positive regulation of defense response to virus by host (GO:0002230) | 2.82992516 |
| 109 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.82713584 |
| 110 | positive regulation of antigen processing and presentation (GO:0002579) | 2.82654975 |
| 111 | endothelium development (GO:0003158) | 2.79763325 |
| 112 | protein localization to synapse (GO:0035418) | 2.79223551 |
| 113 | cellular response to interleukin-15 (GO:0071350) | 2.79179920 |
| 114 | behavioral response to cocaine (GO:0048148) | 2.78841543 |
| 115 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.75440467 |
| 116 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.74895184 |
| 117 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.74511761 |
| 118 | * response to radiation (GO:0009314) | 2.74119987 |
| 119 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.71852078 |
| 120 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.70946798 |
| 121 | thymic T cell selection (GO:0045061) | 2.70050048 |
| 122 | positive regulation of cyclase activity (GO:0031281) | 2.68128012 |
| 123 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.68002777 |
| 124 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.66792779 |
| 125 | neutrophil activation involved in immune response (GO:0002283) | 2.66757076 |
| 126 | cellular response to electrical stimulus (GO:0071257) | 2.66682058 |
| 127 | negative regulation of cation channel activity (GO:2001258) | 2.66001958 |
| 128 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.65252851 |
| 129 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.64954880 |
| 130 | response to interleukin-15 (GO:0070672) | 2.64578312 |
| 131 | purine-containing compound salvage (GO:0043101) | 2.64349818 |
| 132 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.64114442 |
| 133 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.63783937 |
| 134 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.63783937 |
| 135 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.63113895 |
| 136 | terpenoid metabolic process (GO:0006721) | 2.61312014 |
| 137 | aggressive behavior (GO:0002118) | 2.61200484 |
| 138 | positive regulation of icosanoid secretion (GO:0032305) | 2.61061363 |
| 139 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.60311370 |
| 140 | dopamine receptor signaling pathway (GO:0007212) | 2.59561480 |
| 141 | retinol metabolic process (GO:0042572) | 2.59211133 |
| 142 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.59096819 |
| 143 | regulation of neurotransmitter uptake (GO:0051580) | 2.58335476 |
| 144 | axoneme assembly (GO:0035082) | 2.57025820 |
| 145 | mast cell degranulation (GO:0043303) | 2.56501138 |
| 146 | mast cell activation involved in immune response (GO:0002279) | 2.56501138 |
| 147 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.56447346 |
| 148 | positive regulation of interleukin-4 production (GO:0032753) | 2.56249066 |
| 149 | regulation of antigen processing and presentation (GO:0002577) | 2.55726049 |
| 150 | lymph node development (GO:0048535) | 2.55093519 |
| 151 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.54852350 |
| 152 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.54686324 |
| 153 | regulation of catecholamine metabolic process (GO:0042069) | 2.54404712 |
| 154 | regulation of dopamine metabolic process (GO:0042053) | 2.54404712 |
| 155 | T cell selection (GO:0045058) | 2.54025943 |
| 156 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.53385364 |
| 157 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.53097229 |
| 158 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.52399445 |
| 159 | leukocyte degranulation (GO:0043299) | 2.52129478 |
| 160 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.50979414 |
| 161 | positive regulation of T cell mediated immunity (GO:0002711) | 2.50865001 |
| 162 | phospholipid translocation (GO:0045332) | 2.50376654 |
| 163 | lipid translocation (GO:0034204) | 2.50376654 |
| 164 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.50284253 |
| 165 | mature B cell differentiation involved in immune response (GO:0002313) | 2.49623412 |
| 166 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.49471471 |
| 167 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.49290328 |
| 168 | negative regulation of innate immune response (GO:0045824) | 2.48368922 |
| 169 | post-embryonic morphogenesis (GO:0009886) | 2.48255090 |
| 170 | T cell migration (GO:0072678) | 2.47552947 |
| 171 | nucleotide salvage (GO:0043173) | 2.47203462 |
| 172 | positive regulation of lyase activity (GO:0051349) | 2.47169507 |
| 173 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.47157582 |
| 174 | * cellular response to abiotic stimulus (GO:0071214) | 2.35992779 |
| 175 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.34444027 |
| 176 | righting reflex (GO:0060013) | 2.32977450 |
| 177 | fatty acid derivative transport (GO:1901571) | 2.30854372 |
| 178 | icosanoid transport (GO:0071715) | 2.30854372 |
| 179 | positive regulation of membrane potential (GO:0045838) | 2.21072749 |
| 180 | sensory perception of smell (GO:0007608) | 2.18744612 |
| 181 | * regulation of rhodopsin mediated signaling pathway (GO:0022400) | 18.4234368 |
| 182 | retinal cone cell development (GO:0046549) | 17.9264620 |
| 183 | * rhodopsin mediated signaling pathway (GO:0016056) | 17.8583685 |
| 184 | photoreceptor cell development (GO:0042461) | 12.5725943 |
| 185 | eye photoreceptor cell development (GO:0042462) | 12.1862605 |
| 186 | photoreceptor cell maintenance (GO:0045494) | 11.9537730 |
| 187 | detection of light stimulus involved in visual perception (GO:0050908) | 11.7951459 |
| 188 | detection of light stimulus involved in sensory perception (GO:0050962) | 11.7951459 |
| 189 | positive regulation of guanylate cyclase activity (GO:0031284) | 11.6227662 |
| 190 | * phototransduction (GO:0007602) | 10.8583013 |
| 191 | * phototransduction, visible light (GO:0007603) | 10.6461493 |
| 192 | regulation of guanylate cyclase activity (GO:0031282) | 10.5526875 |
| 193 | protein-chromophore linkage (GO:0018298) | 10.4760951 |
| 194 | * detection of light stimulus (GO:0009583) | 10.2481941 |
| 195 | * detection of visible light (GO:0009584) | 10.2034787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.97552296 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.61593176 |
| 3 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 5.10525876 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 4.94958317 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.41246817 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 4.03239972 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.67169430 |
| 8 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.57970467 |
| 9 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 3.16413991 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.02475333 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.83389474 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.68396510 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.64673504 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.62365284 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.56754580 |
| 16 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.55894003 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.53621212 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.43643876 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.43021792 |
| 20 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.39684092 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.31870600 |
| 22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.23040159 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 2.21045450 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.17613801 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.17385533 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13439355 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 2.12562211 |
| 28 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.11720985 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.07898038 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.99482760 |
| 31 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98457304 |
| 32 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.96478676 |
| 33 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.92110299 |
| 34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.90311760 |
| 35 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.89817943 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.88313479 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.86482009 |
| 38 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.85017236 |
| 39 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.83643358 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 1.80814381 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.78762565 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.78359623 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77988604 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.76552509 |
| 45 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.75796985 |
| 46 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.73110952 |
| 47 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.72454271 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.70038592 |
| 49 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.68938560 |
| 50 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.68238824 |
| 51 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.66671855 |
| 52 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.65039478 |
| 53 | GATA3_26560356_Chip-Seq_TH2_Human | 1.63784207 |
| 54 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.62372768 |
| 55 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59984636 |
| 56 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.59670970 |
| 57 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.59602830 |
| 58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59110930 |
| 59 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.59057196 |
| 60 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.58215846 |
| 61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.57900096 |
| 62 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.54697553 |
| 63 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.54673824 |
| 64 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.54243331 |
| 65 | MYC_22102868_ChIP-Seq_BL_Human | 1.53347003 |
| 66 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.51878187 |
| 67 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.51433541 |
| 68 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.50977918 |
| 69 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.50769895 |
| 70 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.49944746 |
| 71 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.48763584 |
| 72 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.48156317 |
| 73 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48156220 |
| 74 | KDM2B_26808549_Chip-Seq_K562_Human | 1.48045732 |
| 75 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.47203363 |
| 76 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.46865190 |
| 77 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.46559543 |
| 78 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.45698003 |
| 79 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.45683094 |
| 80 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.43799792 |
| 81 | AR_19668381_ChIP-Seq_PC3_Human | 1.42080654 |
| 82 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40939419 |
| 83 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.40858607 |
| 84 | MAF_26560356_Chip-Seq_TH2_Human | 1.39334204 |
| 85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37673416 |
| 86 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.36986878 |
| 87 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.36682548 |
| 88 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36217287 |
| 89 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35191949 |
| 90 | TBL1_22424771_ChIP-Seq_293T_Human | 1.34142349 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.32544946 |
| 92 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.32322707 |
| 93 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.30208818 |
| 94 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.29429067 |
| 95 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.28735393 |
| 96 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.28074433 |
| 97 | P300_27268052_Chip-Seq_Bcells_Human | 1.26966678 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25054931 |
| 99 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.25051513 |
| 100 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.24877163 |
| 101 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.23658135 |
| 102 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.23457226 |
| 103 | NCOR_22424771_ChIP-Seq_293T_Human | 1.23006001 |
| 104 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.21356372 |
| 105 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.19925035 |
| 106 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.18940949 |
| 107 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18912995 |
| 108 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.17671155 |
| 109 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16710122 |
| 110 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.15997943 |
| 111 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14992150 |
| 112 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.14959606 |
| 113 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.14927814 |
| 114 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14651393 |
| 115 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14016747 |
| 116 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.13249050 |
| 117 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12874286 |
| 118 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.12657891 |
| 119 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12105741 |
| 120 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.12044188 |
| 121 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11847555 |
| 122 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.11461739 |
| 123 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.11062209 |
| 124 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.10638199 |
| 125 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.10526518 |
| 126 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.10406907 |
| 127 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.10101613 |
| 128 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09893506 |
| 129 | GF1_26923725_Chip-Seq_HPCs_Mouse | 1.09838852 |
| 130 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.09811137 |
| 131 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09519596 |
| 132 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09514266 |
| 133 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.08936061 |
| 134 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.08850103 |
| 135 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08819007 |
| 136 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08538423 |
| 137 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.08332147 |
| 138 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08183980 |
| 139 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.08107839 |
| 140 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.08028580 |
| 141 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.07697635 |
| 142 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.07386618 |
| 143 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.06506946 |
| 144 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.06343892 |
| 145 | P68_20966046_ChIP-Seq_HELA_Human | 1.05524617 |
| 146 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.05395195 |
| 147 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.05252498 |
| 148 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.04944236 |
| 149 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.04670265 |
| 150 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04562112 |
| 151 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.03896847 |
| 152 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.03551994 |
| 153 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03394116 |
| 154 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.03298824 |
| 155 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 1.03102281 |
| 156 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.02969324 |
| 157 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02669848 |
| 158 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.02244364 |
| 159 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01749867 |
| 160 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.01451928 |
| 161 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00810181 |
| 162 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00155670 |
| 163 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.99431853 |
| 164 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99341781 |
| 165 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.99194474 |
| 166 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.98187133 |
| 167 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.98187133 |
| 168 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97631589 |
| 169 | CBP_21632823_ChIP-Seq_H3396_Human | 0.97273301 |
| 170 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.96657052 |
| 171 | SA1_27219007_Chip-Seq_Bcells_Human | 0.96638825 |
| 172 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95221669 |
| 173 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.95206970 |
| 174 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.94698287 |
| 175 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94460222 |
| 176 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.93900043 |
| 177 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93416145 |
| 178 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93395787 |
| 179 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92471154 |
| 180 | P300_19829295_ChIP-Seq_ESCs_Human | 0.91233123 |
| 181 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.88694073 |
| 182 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88616870 |
| 183 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.87083251 |
| 184 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86305060 |
| 185 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.85332516 |
| 186 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.85154349 |
| 187 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84428640 |
| 188 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.84054564 |
| 189 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83768733 |
| 190 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.83756793 |
| 191 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.83654693 |
| 192 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83397995 |
| 193 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83057532 |
| 194 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.82618241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005551_abnormal_eye_electrophysiolog | 9.87822047 |
| 2 | MP0005253_abnormal_eye_physiology | 7.09712919 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 6.62390332 |
| 4 | MP0003950_abnormal_plasma_membrane | 4.12272615 |
| 5 | MP0003724_increased_susceptibility_to | 3.83537374 |
| 6 | * MP0005195_abnormal_posterior_eye | 3.81753936 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.61282279 |
| 8 | MP0001324_abnormal_eye_pigmentation | 3.47094145 |
| 9 | MP0005391_vision/eye_phenotype | 3.44696425 |
| 10 | MP0005671_abnormal_response_to | 3.22941241 |
| 11 | MP0000685_abnormal_immune_system | 2.94945713 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.94842066 |
| 13 | MP0002090_abnormal_vision | 2.92363309 |
| 14 | MP0003436_decreased_susceptibility_to | 2.88863091 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.86110059 |
| 16 | MP0001986_abnormal_taste_sensitivity | 2.82158732 |
| 17 | MP0002638_abnormal_pupillary_reflex | 2.75166133 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.69141228 |
| 19 | MP0002229_neurodegeneration | 2.59259026 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.48931687 |
| 21 | MP0001800_abnormal_humoral_immune | 2.36668414 |
| 22 | MP0002723_abnormal_immune_serum | 2.26419122 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 2.23956551 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.22382536 |
| 25 | MP0001819_abnormal_immune_cell | 2.19402056 |
| 26 | MP0002452_abnormal_antigen_presenting | 2.13701377 |
| 27 | MP0002419_abnormal_innate_immunity | 2.12520414 |
| 28 | MP0001764_abnormal_homeostasis | 2.11612988 |
| 29 | MP0005025_abnormal_response_to | 2.11252316 |
| 30 | MP0005387_immune_system_phenotype | 2.10672969 |
| 31 | MP0001790_abnormal_immune_system | 2.10672969 |
| 32 | MP0002398_abnormal_bone_marrow | 2.05141401 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 2.01715351 |
| 34 | MP0003011_delayed_dark_adaptation | 10.8747088 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.95485480 |
| 36 | * MP0002752_abnormal_somatic_nervous | 1.90917191 |
| 37 | MP0009785_altered_susceptibility_to | 1.83722341 |
| 38 | MP0000716_abnormal_immune_system | 1.83188125 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.68623111 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.65439590 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.65439590 |
| 42 | MP0005075_abnormal_melanosome_morpholog | 1.62708435 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.62090095 |
| 44 | MP0002429_abnormal_blood_cell | 1.58689971 |
| 45 | MP0002722_abnormal_immune_system | 1.55792306 |
| 46 | MP0002405_respiratory_system_inflammati | 1.53443097 |
| 47 | MP0004147_increased_porphyrin_level | 1.50667856 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.50584445 |
| 49 | MP0004019_abnormal_vitamin_homeostasis | 1.48729066 |
| 50 | MP0003866_abnormal_defecation | 1.48202768 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.47409208 |
| 52 | MP0003878_abnormal_ear_physiology | 1.45568109 |
| 53 | MP0005377_hearing/vestibular/ear_phenot | 1.45568109 |
| 54 | MP0009278_abnormal_bone_marrow | 1.42757759 |
| 55 | MP0002653_abnormal_ependyma_morphology | 1.42025665 |
| 56 | MP0009764_decreased_sensitivity_to | 1.37395844 |
| 57 | MP0005058_abnormal_lysosome_morphology | 1.33803495 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.33612527 |
| 59 | * MP0002882_abnormal_neuron_morphology | 1.32298197 |
| 60 | MP0009840_abnormal_foam_cell | 1.30784047 |
| 61 | MP0003303_peritoneal_inflammation | 1.24025762 |
| 62 | MP0000703_abnormal_thymus_morphology | 1.23451644 |
| 63 | MP0002166_altered_tumor_susceptibility | 1.22464439 |
| 64 | MP0004233_abnormal_muscle_weight | 1.15897940 |
| 65 | MP0005645_abnormal_hypothalamus_physiol | 1.12717808 |
| 66 | MP0008469_abnormal_protein_level | 1.08782868 |
| 67 | MP0001984_abnormal_olfaction | 1.02931187 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.00784858 |
| 69 | MP0005197_abnormal_uvea_morphology | 0.99798080 |
| 70 | MP0001853_heart_inflammation | 0.98754009 |
| 71 | MP0005174_abnormal_tail_pigmentation | 0.97198978 |
| 72 | MP0006292_abnormal_olfactory_placode | 0.96051497 |
| 73 | MP0008872_abnormal_physiological_respon | 0.95363418 |
| 74 | MP0002006_tumorigenesis | 0.93973530 |
| 75 | MP0004947_skin_inflammation | 0.93735021 |
| 76 | MP0002332_abnormal_exercise_endurance | 0.92751395 |
| 77 | MP0001502_abnormal_circadian_rhythm | 0.91802525 |
| 78 | MP0006036_abnormal_mitochondrial_physio | 0.91501790 |
| 79 | MP0002127_abnormal_cardiovascular_syste | 0.89965349 |
| 80 | MP0004885_abnormal_endolymph | 0.89138567 |
| 81 | MP0005410_abnormal_fertilization | 0.88869977 |
| 82 | MP0003075_altered_response_to | 0.86007079 |
| 83 | MP0002396_abnormal_hematopoietic_system | 0.85276906 |
| 84 | MP0003172_abnormal_lysosome_physiology | 0.85086502 |
| 85 | MP0002019_abnormal_tumor_incidence | 0.84155607 |
| 86 | MP0008875_abnormal_xenobiotic_pharmacok | 0.79224379 |
| 87 | MP0005499_abnormal_olfactory_system | 0.79081053 |
| 88 | MP0005394_taste/olfaction_phenotype | 0.79081053 |
| 89 | MP0006082_CNS_inflammation | 0.79001565 |
| 90 | MP0009763_increased_sensitivity_to | 0.78790031 |
| 91 | MP0002132_abnormal_respiratory_system | 0.78721458 |
| 92 | MP0005390_skeleton_phenotype | 0.78343807 |
| 93 | MP0001486_abnormal_startle_reflex | 0.77815878 |
| 94 | MP0002933_joint_inflammation | 0.73940712 |
| 95 | MP0001881_abnormal_mammary_gland | 0.72333984 |
| 96 | MP0008789_abnormal_olfactory_epithelium | 0.71090974 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.69400928 |
| 98 | MP0004270_analgesia | 0.69167987 |
| 99 | MP0003828_pulmonary_edema | 0.68034769 |
| 100 | MP0003634_abnormal_glial_cell | 0.67625768 |
| 101 | MP0002272_abnormal_nervous_system | 0.67350420 |
| 102 | MP0001663_abnormal_digestive_system | 0.66261972 |
| 103 | MP0002998_abnormal_bone_remodeling | 0.66124557 |
| 104 | MP0005165_increased_susceptibility_to | 0.65101016 |
| 105 | MP0004808_abnormal_hematopoietic_stem | 0.63741206 |
| 106 | MP0002095_abnormal_skin_pigmentation | 0.62621044 |
| 107 | MP0005187_abnormal_penis_morphology | 0.61357759 |
| 108 | MP0000372_irregular_coat_pigmentation | 0.60683371 |
| 109 | MP0008260_abnormal_autophagy | 0.60679402 |
| 110 | MP0001286_abnormal_eye_development | 0.59681448 |
| 111 | MP0009643_abnormal_urine_homeostasis | 0.57398828 |
| 112 | MP0000465_gastrointestinal_hemorrhage | 0.56846230 |
| 113 | MP0005535_abnormal_body_temperature | 0.56697580 |
| 114 | MP0001963_abnormal_hearing_physiology | 0.54451709 |
| 115 | MP0005166_decreased_susceptibility_to | 0.54445797 |
| 116 | MP0005167_abnormal_blood-brain_barrier | 0.53391497 |
| 117 | MP0000358_abnormal_cell_content/ | 0.51826276 |
| 118 | MP0005636_abnormal_mineral_homeostasis | 0.48186707 |
| 119 | MP0002734_abnormal_mechanical_nocicepti | 0.47594226 |
| 120 | MP0005376_homeostasis/metabolism_phenot | 0.47150230 |
| 121 | MP0008004_abnormal_stomach_pH | 0.47027508 |
| 122 | MP0003880_abnormal_central_pattern | 0.42971246 |
| 123 | MP0003045_fibrosis | 0.38808932 |
| 124 | MP0002064_seizures | 0.37874747 |
| 125 | MP0008058_abnormal_DNA_repair | 0.37780010 |
| 126 | MP0009046_muscle_twitch | 0.36755264 |
| 127 | MP0002572_abnormal_emotion/affect_behav | 0.35922030 |
| 128 | MP0004145_abnormal_muscle_electrophysio | 0.33272623 |
| 129 | MP0002067_abnormal_sensory_capabilities | 0.33112187 |
| 130 | MP0001905_abnormal_dopamine_level | 0.33095792 |
| 131 | MP0004782_abnormal_surfactant_physiolog | 0.32981050 |
| 132 | MP0004142_abnormal_muscle_tone | 0.32092848 |
| 133 | MP0000631_abnormal_neuroendocrine_gland | 0.31134883 |
| 134 | MP0000026_abnormal_inner_ear | 0.31093331 |
| 135 | MP0001661_extended_life_span | 0.31059005 |
| 136 | MP0003635_abnormal_synaptic_transmissio | 0.30484675 |
| 137 | MP0004924_abnormal_behavior | 0.29179955 |
| 138 | MP0005386_behavior/neurological_phenoty | 0.29179955 |
| 139 | MP0002063_abnormal_learning/memory/cond | 0.28903382 |
| 140 | MP0004742_abnormal_vestibular_system | 0.28758024 |
| 141 | MP0003646_muscle_fatigue | 0.27648205 |
| 142 | MP0001968_abnormal_touch/_nociception | 0.27117956 |
| 143 | MP0005620_abnormal_muscle_contractility | 0.26629503 |
| 144 | MP0010386_abnormal_urinary_bladder | 0.25325994 |
| 145 | MP0003890_abnormal_embryonic-extraembry | 0.25284639 |
| 146 | MP0009745_abnormal_behavioral_response | 0.24397493 |
| 147 | MP0004215_abnormal_myocardial_fiber | 0.23677441 |
| 148 | MP0004085_abnormal_heartbeat | 0.23601186 |
| 149 | MP0005076_abnormal_cell_differentiation | 0.23359826 |
| 150 | MP0004859_abnormal_synaptic_plasticity | 0.22942821 |
| 151 | MP0005595_abnormal_vascular_smooth | 0.22096060 |
| 152 | MP0003638_abnormal_response/metabolism_ | 0.20784401 |
| 153 | MP0005646_abnormal_pituitary_gland | 0.20707430 |
| 154 | MP0002102_abnormal_ear_morphology | 0.18762056 |
| 155 | MP0002108_abnormal_muscle_morphology | 0.18113040 |
| 156 | MP0005193_abnormal_anterior_eye | 0.17333579 |
| 157 | MP0002152_abnormal_brain_morphology | 0.16698383 |
| 158 | MP0001915_intracranial_hemorrhage | 0.16655261 |
| 159 | MP0002066_abnormal_motor_capabilities/c | 0.15429354 |
| 160 | MP0004043_abnormal_pH_regulation | 0.14234995 |
| 161 | MP0005330_cardiomyopathy | 0.13237086 |
| 162 | MP0001188_hyperpigmentation | 0.12948604 |
| 163 | MP0010030_abnormal_orbit_morphology | 0.12163201 |
| 164 | MP0002697_abnormal_eye_size | 0.11796094 |
| 165 | MP0005248_abnormal_Harderian_gland | 0.10481227 |
| 166 | MP0003943_abnormal_hepatobiliary_system | 0.10367903 |
| 167 | MP0008569_lethality_at_weaning | 0.10267887 |
| 168 | MP0005266_abnormal_metabolism | 0.10114276 |
| 169 | MP0005084_abnormal_gallbladder_morpholo | 0.09933186 |
| 170 | MP0000001_mammalian_phenotype | 0.09856548 |
| 171 | MP0005310_abnormal_salivary_gland | 0.09481186 |
| 172 | MP0002168_other_aberrant_phenotype | 0.09477498 |
| 173 | MP0004811_abnormal_neuron_physiology | 0.09362576 |
| 174 | MP0002184_abnormal_innervation | 0.08726918 |
| 175 | MP0003632_abnormal_nervous_system | 0.08404180 |
| 176 | MP0003252_abnormal_bile_duct | 0.07955462 |
| 177 | MP0002928_abnormal_bile_duct | 0.07642102 |
| 178 | MP0000751_myopathy | 0.07365721 |
| 179 | MP0001614_abnormal_blood_vessel | 0.07293168 |
| 180 | MP0002557_abnormal_social/conspecific_i | 0.07056361 |
| 181 | MP0000749_muscle_degeneration | 0.05801527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pigmentary retinal degeneration (HP:0001146) | 9.56845400 |
| 2 | Chorioretinal atrophy (HP:0000533) | 8.20772532 |
| 3 | Abnormality of macular pigmentation (HP:0008002) | 8.16542492 |
| 4 | Central scotoma (HP:0000603) | 8.16438134 |
| 5 | Pendular nystagmus (HP:0012043) | 7.62885548 |
| 6 | Scotoma (HP:0000575) | 7.33162768 |
| 7 | * Attenuation of retinal blood vessels (HP:0007843) | 6.62267983 |
| 8 | Decreased central vision (HP:0007663) | 6.58095922 |
| 9 | Abolished electroretinogram (ERG) (HP:0000550) | 6.38386805 |
| 10 | * Photophobia (HP:0000613) | 5.84811744 |
| 11 | * Type II diabetes mellitus (HP:0005978) | 5.50360093 |
| 12 | Vitreoretinal degeneration (HP:0000655) | 5.43578314 |
| 13 | Macular degeneration (HP:0000608) | 5.16000352 |
| 14 | Severe visual impairment (HP:0001141) | 4.74916062 |
| 15 | Choroideremia (HP:0001139) | 4.72671277 |
| 16 | Posterior subcapsular cataract (HP:0007787) | 4.72325878 |
| 17 | Keratoconus (HP:0000563) | 4.61885112 |
| 18 | Increased corneal curvature (HP:0100692) | 4.61885112 |
| 19 | Cone-rod dystrophy (HP:0000548) | 4.57900762 |
| 20 | Retinitis pigmentosa (HP:0000510) | 4.49587169 |
| 21 | Constricted visual fields (HP:0001133) | 4.19018169 |
| 22 | Agammaglobulinemia (HP:0004432) | 3.97768468 |
| 23 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.57620728 |
| 24 | Abnormality of B cell number (HP:0010975) | 3.36509653 |
| 25 | Panhypogammaglobulinemia (HP:0003139) | 3.36079229 |
| 26 | Severe combined immunodeficiency (HP:0004430) | 3.34633017 |
| 27 | Myositis (HP:0100614) | 3.10112407 |
| 28 | Progressive visual loss (HP:0000529) | 3.02909337 |
| 29 | Abnormality of the prostate (HP:0008775) | 3.00514493 |
| 30 | Lipid accumulation in hepatocytes (HP:0006561) | 2.92317757 |
| 31 | 3-Methylglutaconic aciduria (HP:0003535) | 2.89910944 |
| 32 | B lymphocytopenia (HP:0010976) | 2.89630482 |
| 33 | Combined immunodeficiency (HP:0005387) | 2.88465905 |
| 34 | Subcapsular cataract (HP:0000523) | 2.86222617 |
| 35 | Stomatitis (HP:0010280) | 2.85998513 |
| 36 | Autoimmune thrombocytopenia (HP:0001973) | 2.83746535 |
| 37 | Abnormal number of erythroid precursors (HP:0012131) | 2.83452551 |
| 38 | Recurrent fungal infections (HP:0002841) | 2.82368901 |
| 39 | Retinal atrophy (HP:0001105) | 2.80854153 |
| 40 | Chronic otitis media (HP:0000389) | 2.77267527 |
| 41 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.75744290 |
| 42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.74663460 |
| 43 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.74174533 |
| 44 | Prolonged bleeding time (HP:0003010) | 2.72682173 |
| 45 | Meningitis (HP:0001287) | 2.72415390 |
| 46 | Petechiae (HP:0000967) | 2.72311994 |
| 47 | Increased IgM level (HP:0003496) | 2.70603133 |
| 48 | Recurrent viral infections (HP:0004429) | 2.70134693 |
| 49 | Congenital sensorineural hearing impairment (HP:0008527) | 2.70114211 |
| 50 | Abnormality of T cell number (HP:0011839) | 2.69564082 |
| 51 | T lymphocytopenia (HP:0005403) | 2.69444608 |
| 52 | Dry hair (HP:0011359) | 2.68318760 |
| 53 | Abnormality of T cells (HP:0002843) | 2.66204812 |
| 54 | Increased muscle lipid content (HP:0009058) | 2.64945083 |
| 55 | Recurrent cutaneous fungal infections (HP:0011370) | 2.63066725 |
| 56 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.63066725 |
| 57 | IgG deficiency (HP:0004315) | 2.60186285 |
| 58 | Retrobulbar optic neuritis (HP:0100654) | 2.58874748 |
| 59 | Optic neuritis (HP:0100653) | 2.58874748 |
| 60 | Gait imbalance (HP:0002141) | 2.53498692 |
| 61 | Congenital primary aphakia (HP:0007707) | 2.52215670 |
| 62 | Abnormality of eosinophils (HP:0001879) | 2.49459747 |
| 63 | Encephalitis (HP:0002383) | 2.47139373 |
| 64 | Orchitis (HP:0100796) | 2.46745958 |
| 65 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.45838390 |
| 66 | Increased cerebral lipofuscin (HP:0011813) | 2.45221939 |
| 67 | Granulocytopenia (HP:0001913) | 2.44265611 |
| 68 | * Wide nasal bridge (HP:0000431) | 2.43766988 |
| 69 | Thyroiditis (HP:0100646) | 2.42177622 |
| 70 | Abnormality of iron homeostasis (HP:0011031) | 2.41415652 |
| 71 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.40976416 |
| 72 | Increased hepatocellular lipid droplets (HP:0006565) | 2.39721388 |
| 73 | Pulmonary infiltrates (HP:0002113) | 2.36852400 |
| 74 | Prostate neoplasm (HP:0100787) | 2.36522739 |
| 75 | Autoimmune hemolytic anemia (HP:0001890) | 2.35627453 |
| 76 | Epistaxis (HP:0000421) | 2.35460734 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.35075532 |
| 78 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.35075532 |
| 79 | Recurrent abscess formation (HP:0002722) | 2.34729981 |
| 80 | Premature loss of primary teeth (HP:0006323) | 2.32287381 |
| 81 | Increased serum ferritin (HP:0003281) | 2.31697546 |
| 82 | Increased intramyocellular lipid droplets (HP:0012240) | 2.31419607 |
| 83 | Dysostosis multiplex (HP:0000943) | 2.31411897 |
| 84 | Eosinophilia (HP:0001880) | 2.30985369 |
| 85 | Abnormality of T cell physiology (HP:0011840) | 2.29330903 |
| 86 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.29231565 |
| 87 | * Optic disc pallor (HP:0000543) | 2.28098281 |
| 88 | Mitochondrial inheritance (HP:0001427) | 2.27803268 |
| 89 | Leukocytosis (HP:0001974) | 2.25090156 |
| 90 | Nephrogenic diabetes insipidus (HP:0009806) | 2.23993090 |
| 91 | Type I transferrin isoform profile (HP:0003642) | 2.21828584 |
| 92 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.21606900 |
| 93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.21606900 |
| 94 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.21606900 |
| 95 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.21054336 |
| 96 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.21054336 |
| 97 | Abnormality of glycolipid metabolism (HP:0010969) | 2.21054336 |
| 98 | Medial flaring of the eyebrow (HP:0010747) | 2.19189771 |
| 99 | Recurrent bacterial skin infections (HP:0005406) | 2.18154363 |
| 100 | Increased density of long bones (HP:0006392) | 2.14916873 |
| 101 | Mediastinal lymphadenopathy (HP:0100721) | 2.14254754 |
| 102 | Recurrent skin infections (HP:0001581) | 2.14124474 |
| 103 | Recurrent bronchitis (HP:0002837) | 2.13075328 |
| 104 | Hepatocellular necrosis (HP:0001404) | 2.12881568 |
| 105 | Aplastic anemia (HP:0001915) | 2.12763043 |
| 106 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.11808062 |
| 107 | Pallor (HP:0000980) | 2.11389033 |
| 108 | Obstructive lung disease (HP:0006536) | 2.10294187 |
| 109 | Chronic obstructive pulmonary disease (HP:0006510) | 2.10294187 |
| 110 | Hepatic necrosis (HP:0002605) | 2.09210678 |
| 111 | Spastic paraparesis (HP:0002313) | 2.06784575 |
| 112 | Hepatosplenomegaly (HP:0001433) | 2.04625683 |
| 113 | Increased CSF lactate (HP:0002490) | 2.04133878 |
| 114 | Vasculitis (HP:0002633) | 2.02133565 |
| 115 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.01572437 |
| 116 | IgM deficiency (HP:0002850) | 2.01283912 |
| 117 | Acute encephalopathy (HP:0006846) | 2.01282104 |
| 118 | Cellulitis (HP:0100658) | 2.00300936 |
| 119 | Congenital stationary night blindness (HP:0007642) | 15.5947336 |
| 120 | Bony spicule pigmentary retinopathy (HP:0007737) | 11.7611552 |
| 121 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 10.5066797 |
| 122 | Dyschromatopsia (HP:0007641) | 10.3009010 |
| 123 | Abnormal rod and cone electroretinograms (HP:0008323) | 10.0085861 |
| 124 | Poor coordination (HP:0002370) | 1.93897935 |
| 125 | Vaginal atresia (HP:0000148) | 1.72650525 |
| 126 | Horizontal nystagmus (HP:0000666) | 1.67254480 |
| 127 | Genital tract atresia (HP:0001827) | 1.65339973 |
| 128 | True hermaphroditism (HP:0010459) | 1.62112576 |
| 129 | * Optic atrophy (HP:0000648) | 1.58623408 |
| 130 | Polar cataract (HP:0010696) | 1.52185302 |
| 131 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.42750369 |
| 132 | Interstitial pulmonary disease (HP:0006530) | 1.42736498 |
| 133 | Severe Myopia (HP:0011003) | 1.40161308 |
| 134 | Pancreatic fibrosis (HP:0100732) | 1.31060213 |
| 135 | Dysdiadochokinesis (HP:0002075) | 1.25832015 |
| 136 | Astigmatism (HP:0000483) | 1.18505143 |
| 137 | Retinal detachment (HP:0000541) | 1.17289242 |
| 138 | Epileptic encephalopathy (HP:0200134) | 1.09415445 |
| 139 | Pancreatic cysts (HP:0001737) | 1.08195573 |
| 140 | Broad foot (HP:0001769) | 1.07754441 |
| 141 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.05547123 |
| 142 | Hypoplasia of the fovea (HP:0007750) | 1.05547123 |
| 143 | Febrile seizures (HP:0002373) | 1.05504083 |
| 144 | Abnormality of the fovea (HP:0000493) | 1.04763112 |
| 145 | Cystic liver disease (HP:0006706) | 1.00793594 |
| 146 | Left ventricular hypertrophy (HP:0001712) | 0.99976839 |
| 147 | Decreased testicular size (HP:0008734) | 0.97752879 |
| 148 | Recurrent sinusitis (HP:0011108) | 0.97735309 |
| 149 | Specific learning disability (HP:0001328) | 0.97293271 |
| 150 | Asthma (HP:0002099) | 0.94381153 |
| 151 | Chorioretinal coloboma (HP:0000567) | 0.93134118 |
| 152 | Cerebellar dysplasia (HP:0007033) | 0.91917246 |
| 153 | Progressive cerebellar ataxia (HP:0002073) | 0.90692885 |
| 154 | Truncal ataxia (HP:0002078) | 0.86440903 |
| 155 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 0.86092954 |
| 156 | Sclerocornea (HP:0000647) | 0.84264427 |
| 157 | Abnormality of dental color (HP:0011073) | 0.84110424 |
| 158 | Hypermetropia (HP:0000540) | 0.79164057 |
| 159 | Aplasia/Hypoplasia of the macula (HP:0008059) | 0.77673954 |
| 160 | Abnormality of midbrain morphology (HP:0002418) | 0.76954176 |
| 161 | Molar tooth sign on MRI (HP:0002419) | 0.76954176 |
| 162 | Dental crowding (HP:0000678) | 0.71039732 |
| 163 | Genetic anticipation (HP:0003743) | 0.70360413 |
| 164 | Partial agenesis of the corpus callosum (HP:0001338) | 0.69876201 |
| 165 | Anencephaly (HP:0002323) | 0.69800327 |
| 166 | Postaxial hand polydactyly (HP:0001162) | 0.67799454 |
| 167 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 0.67793858 |
| 168 | Short foot (HP:0001773) | 0.67565123 |
| 169 | Chronic hepatic failure (HP:0100626) | 0.67491350 |
| 170 | Furrowed tongue (HP:0000221) | 0.67037678 |
| 171 | Hypodontia (HP:0000668) | 0.66868342 |
| 172 | Lymphopenia (HP:0001888) | 0.65424865 |
| 173 | Broad-based gait (HP:0002136) | 0.64974196 |
| 174 | Congenital hepatic fibrosis (HP:0002612) | 0.61348816 |
| 175 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 0.61313656 |
| 176 | Osteomalacia (HP:0002749) | 0.60995038 |
| 177 | Nephronophthisis (HP:0000090) | 0.60876389 |
| 178 | Aqueductal stenosis (HP:0002410) | 0.60619935 |
| 179 | Prolonged QT interval (HP:0001657) | 0.60386473 |
| 180 | Polycystic ovaries (HP:0000147) | 0.59319755 |
| 181 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 0.58935552 |
| 182 | Nephrotic syndrome (HP:0000100) | 0.58882634 |
| 183 | Corneal dystrophy (HP:0001131) | 0.57246859 |
| 184 | Anal stenosis (HP:0002025) | 0.55273852 |
| 185 | Male pseudohermaphroditism (HP:0000037) | 0.54563055 |
| 186 | Prominent nasal bridge (HP:0000426) | 0.54001085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 7.84837314 |
| 2 | BCKDK | 4.53475832 |
| 3 | MAP4K1 | 4.00899628 |
| 4 | TESK2 | 3.77783122 |
| 5 | KDR | 3.10151721 |
| 6 | PINK1 | 2.92300252 |
| 7 | IRAK2 | 2.86053174 |
| 8 | VRK2 | 2.51360702 |
| 9 | MAP3K14 | 2.37486517 |
| 10 | KIT | 2.32999800 |
| 11 | INSRR | 2.29003874 |
| 12 | TLK1 | 2.25432240 |
| 13 | TXK | 2.03404637 |
| 14 | GRK1 | 11.0038813 |
| 15 | GRK6 | 1.97452221 |
| 16 | SYK | 1.86265581 |
| 17 | CCNB1 | 1.85624490 |
| 18 | CSF1R | 1.84409431 |
| 19 | MAPK7 | 1.84062426 |
| 20 | PIM2 | 1.72228731 |
| 21 | TEC | 1.57932125 |
| 22 | BTK | 1.57422823 |
| 23 | MARK1 | 1.54360830 |
| 24 | IKBKB | 1.53723761 |
| 25 | NUAK1 | 1.52431569 |
| 26 | MAP2K2 | 1.51208143 |
| 27 | NME2 | 1.50953744 |
| 28 | TBK1 | 1.49346595 |
| 29 | ICK | 1.47296289 |
| 30 | PNCK | 1.43722341 |
| 31 | RPS6KA4 | 1.40299187 |
| 32 | CAMK1G | 1.38942916 |
| 33 | TAOK3 | 1.36668444 |
| 34 | SIK2 | 1.36376429 |
| 35 | MAP3K11 | 1.36149541 |
| 36 | SCYL2 | 1.36086023 |
| 37 | RIPK4 | 1.34452338 |
| 38 | BMPR2 | 1.33190365 |
| 39 | MAPK12 | 1.32481527 |
| 40 | BRD4 | 1.32297712 |
| 41 | BLK | 1.32034339 |
| 42 | PRKCQ | 1.31328100 |
| 43 | MATK | 1.30676740 |
| 44 | ITK | 1.28725073 |
| 45 | MAP3K12 | 1.27769656 |
| 46 | JAK3 | 1.27304749 |
| 47 | TAOK2 | 1.26630555 |
| 48 | TTK | 1.26334789 |
| 49 | CDK12 | 1.22862164 |
| 50 | AKT3 | 1.20786246 |
| 51 | LYN | 1.20580474 |
| 52 | CAMK1D | 1.18844384 |
| 53 | MAP3K13 | 1.18674484 |
| 54 | DAPK1 | 1.16812229 |
| 55 | MAPKAPK3 | 1.13623011 |
| 56 | ZAP70 | 1.12655703 |
| 57 | STK38 | 1.10585176 |
| 58 | HIPK2 | 1.10137814 |
| 59 | LCK | 1.09688372 |
| 60 | IKBKE | 1.08822145 |
| 61 | PRKCZ | 1.03047001 |
| 62 | CDK3 | 0.99824440 |
| 63 | VRK1 | 0.99016299 |
| 64 | IRAK4 | 0.98778508 |
| 65 | SGK223 | 0.96844096 |
| 66 | SGK494 | 0.96844096 |
| 67 | FLT3 | 0.95322643 |
| 68 | CSNK1D | 0.94749602 |
| 69 | MAP3K10 | 0.92807919 |
| 70 | MAP4K2 | 0.91906885 |
| 71 | MAPKAPK5 | 0.90984958 |
| 72 | MARK3 | 0.89494125 |
| 73 | TESK1 | 0.88445002 |
| 74 | ERN1 | 0.88124791 |
| 75 | PIM1 | 0.86329256 |
| 76 | PIK3CG | 0.85124407 |
| 77 | ADRBK2 | 0.83776791 |
| 78 | HCK | 0.80621921 |
| 79 | ACVR1B | 0.79854517 |
| 80 | NEK6 | 0.78056652 |
| 81 | NEK2 | 0.75243752 |
| 82 | SGK2 | 0.75020436 |
| 83 | MAP3K4 | 0.74272037 |
| 84 | ERBB2 | 0.73853835 |
| 85 | MYLK | 0.73351612 |
| 86 | CHEK2 | 0.70709537 |
| 87 | CAMK2D | 0.69003534 |
| 88 | SMG1 | 0.68046989 |
| 89 | DAPK2 | 0.67602481 |
| 90 | TIE1 | 0.65746646 |
| 91 | STK16 | 0.65591273 |
| 92 | IRAK1 | 0.64858300 |
| 93 | PAK6 | 0.62185047 |
| 94 | PHKG1 | 0.62097573 |
| 95 | PHKG2 | 0.62097573 |
| 96 | PRKCB | 0.61124348 |
| 97 | ZAK | 0.61088518 |
| 98 | LATS1 | 0.60580306 |
| 99 | MAP3K5 | 0.60419996 |
| 100 | SGK3 | 0.60230484 |
| 101 | TYK2 | 0.60118532 |
| 102 | PRKAA1 | 0.57666571 |
| 103 | PRKACG | 0.57514407 |
| 104 | MKNK2 | 0.57489550 |
| 105 | DYRK2 | 0.57387387 |
| 106 | CSK | 0.56812493 |
| 107 | PRKD2 | 0.56390665 |
| 108 | PRKCH | 0.56249266 |
| 109 | PLK3 | 0.56056543 |
| 110 | PRKD3 | 0.56002143 |
| 111 | WNK1 | 0.54168003 |
| 112 | DYRK1A | 0.53758403 |
| 113 | YES1 | 0.53420698 |
| 114 | JAK1 | 0.52748662 |
| 115 | PRKAA2 | 0.51869363 |
| 116 | CDK4 | 0.51627770 |
| 117 | MKNK1 | 0.51340956 |
| 118 | RPS6KA5 | 0.51072394 |
| 119 | PLK4 | 0.50982756 |
| 120 | LIMK1 | 0.50889960 |
| 121 | CAMK1 | 0.48043109 |
| 122 | TAF1 | 0.47360951 |
| 123 | AKT2 | 0.47119471 |
| 124 | RPS6KA3 | 0.46874782 |
| 125 | LRRK2 | 0.46616985 |
| 126 | PLK2 | 0.45949919 |
| 127 | MAP2K7 | 0.45145117 |
| 128 | ARAF | 0.44597802 |
| 129 | PRKDC | 0.44550794 |
| 130 | CLK1 | 0.43009624 |
| 131 | FES | 0.41562048 |
| 132 | GSK3B | 0.40353977 |
| 133 | CAMK2A | 0.39582867 |
| 134 | GRK5 | 0.39005284 |
| 135 | NEK1 | 0.38921120 |
| 136 | MAPK14 | 0.38793356 |
| 137 | EIF2AK2 | 0.38133792 |
| 138 | MAPK9 | 0.38105488 |
| 139 | CASK | 0.37295777 |
| 140 | CAMKK2 | 0.36890055 |
| 141 | GRK7 | 0.36349384 |
| 142 | SGK1 | 0.35834840 |
| 143 | DYRK1B | 0.35142243 |
| 144 | PKN1 | 0.34844389 |
| 145 | DAPK3 | 0.34491646 |
| 146 | CDK1 | 0.34490251 |
| 147 | STK10 | 0.34472354 |
| 148 | PRKCG | 0.34014413 |
| 149 | CDK9 | 0.33232659 |
| 150 | CAMKK1 | 0.33067367 |
| 151 | PRKACA | 0.32254529 |
| 152 | ATR | 0.32149944 |
| 153 | IGF1R | 0.31708479 |
| 154 | MAPK10 | 0.31363409 |
| 155 | MST4 | 0.31101528 |
| 156 | FYN | 0.30677927 |
| 157 | CAMK4 | 0.30326245 |
| 158 | PDK1 | 0.30017098 |
| 159 | CDC42BPA | 0.28716796 |
| 160 | ABL1 | 0.28565560 |
| 161 | CHEK1 | 0.27617440 |
| 162 | RPS6KB1 | 0.26898510 |
| 163 | RAF1 | 0.26756652 |
| 164 | MAPK11 | 0.26589354 |
| 165 | ATM | 0.26092573 |
| 166 | MAP2K3 | 0.25880923 |
| 167 | CDK5 | 0.25214227 |
| 168 | PRPF4B | 0.24579148 |
| 169 | RPS6KA6 | 0.24313934 |
| 170 | CHUK | 0.24180854 |
| 171 | PRKD1 | 0.23792112 |
| 172 | PRKCD | 0.23638327 |
| 173 | PRKCA | 0.22718800 |
| 174 | CSNK1E | 0.21160897 |
| 175 | STK11 | 0.19267855 |
| 176 | CDK2 | 0.17741246 |
| 177 | TNK2 | 0.16439223 |
| 178 | PLK1 | 0.16310009 |
| 179 | MAPK8 | 0.15126629 |
| 180 | RPS6KB2 | 0.14649518 |
| 181 | CDK7 | 0.14620934 |
| 182 | PRKCI | 0.12440505 |
| 183 | PDK2 | 0.11826404 |
| 184 | ALK | 0.10855557 |
| 185 | AKT1 | 0.10331690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.60501027 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.14681524 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.11942896 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.03818340 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.93805612 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.85223072 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.39983514 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.16528807 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.07506329 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.01427723 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.01398609 |
| 12 | * Phototransduction_Homo sapiens_hsa04744 | 16.3510605 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.99906700 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.98621044 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.87633426 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.75914388 |
| 17 | Proteasome_Homo sapiens_hsa03050 | 1.72189657 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.69774670 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.67226651 |
| 20 | Ribosome_Homo sapiens_hsa03010 | 1.57481495 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46871135 |
| 22 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.36379894 |
| 23 | Olfactory transduction_Homo sapiens_hsa04740 | 1.35960007 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34982539 |
| 25 | RNA polymerase_Homo sapiens_hsa03020 | 1.32503424 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.23225509 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.22996633 |
| 28 | DNA replication_Homo sapiens_hsa03030 | 1.21711021 |
| 29 | Mismatch repair_Homo sapiens_hsa03430 | 1.16721721 |
| 30 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.15523873 |
| 31 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.09320516 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.05387416 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.03388570 |
| 34 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.01075096 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.01029722 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00609594 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97075797 |
| 38 | GABAergic synapse_Homo sapiens_hsa04727 | 0.95431294 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.92310679 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.92267303 |
| 41 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.91811902 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 0.88828982 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 0.88727136 |
| 44 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.87364750 |
| 45 | Measles_Homo sapiens_hsa05162 | 0.86746564 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85623386 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 0.82253778 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81225195 |
| 49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.80583428 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79492116 |
| 51 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77915338 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76421951 |
| 53 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75246940 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74248099 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73009943 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.72472994 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 0.72429029 |
| 58 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.71832333 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.71214326 |
| 60 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.70009102 |
| 61 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.69365669 |
| 62 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.68215912 |
| 63 | Lysosome_Homo sapiens_hsa04142 | 0.67269447 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66392779 |
| 65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65502759 |
| 66 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.64669698 |
| 67 | Morphine addiction_Homo sapiens_hsa05032 | 0.64352141 |
| 68 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.63245837 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62476943 |
| 70 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.61728671 |
| 71 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.61720297 |
| 72 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60128308 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.57837601 |
| 74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.57787362 |
| 75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.57329685 |
| 76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.56090484 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.54890002 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.54860605 |
| 79 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53918614 |
| 80 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48519111 |
| 81 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47526754 |
| 82 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.47018905 |
| 83 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46623972 |
| 84 | * Purine metabolism_Homo sapiens_hsa00230 | 0.45611920 |
| 85 | Influenza A_Homo sapiens_hsa05164 | 0.45014975 |
| 86 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.44230178 |
| 87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42704137 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42700777 |
| 89 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42546183 |
| 90 | Insulin secretion_Homo sapiens_hsa04911 | 0.40992997 |
| 91 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.38840172 |
| 92 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.36450128 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.34784460 |
| 94 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34355329 |
| 95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.33830902 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33444194 |
| 97 | Nicotine addiction_Homo sapiens_hsa05033 | 0.33302132 |
| 98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.32595455 |
| 99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.32545366 |
| 100 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.32263818 |
| 101 | Apoptosis_Homo sapiens_hsa04210 | 0.31471742 |
| 102 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30337537 |
| 103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29974403 |
| 104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.29487956 |
| 105 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29348310 |
| 106 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.28967606 |
| 107 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.28360938 |
| 108 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.27836038 |
| 109 | Phagosome_Homo sapiens_hsa04145 | 0.27701645 |
| 110 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.26844344 |
| 111 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.26577251 |
| 112 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.26224748 |
| 113 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.24536108 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.23971641 |
| 115 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.23933351 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22519470 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22439881 |
| 118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.22322472 |
| 119 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.21169896 |
| 120 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.20269937 |
| 121 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.20144078 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19356129 |
| 123 | Lysine degradation_Homo sapiens_hsa00310 | 0.18741591 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.18645863 |
| 125 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.17432681 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.17417325 |
| 127 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.16534139 |
| 128 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.16475098 |
| 129 | Galactose metabolism_Homo sapiens_hsa00052 | 0.16262141 |
| 130 | Cocaine addiction_Homo sapiens_hsa05030 | 0.15990842 |
| 131 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.15534400 |
| 132 | Salivary secretion_Homo sapiens_hsa04970 | 0.15495007 |
| 133 | Alcoholism_Homo sapiens_hsa05034 | 0.15485570 |
| 134 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.14538573 |
| 135 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.14114445 |
| 136 | Renin secretion_Homo sapiens_hsa04924 | 0.13700190 |
| 137 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11726479 |
| 138 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.11495074 |
| 139 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.11242468 |
| 140 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.11007255 |
| 141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.10799928 |
| 142 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.10623750 |
| 143 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.10044479 |
| 144 | Base excision repair_Homo sapiens_hsa03410 | 0.09931310 |
| 145 | RNA degradation_Homo sapiens_hsa03018 | 0.09893632 |
| 146 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.09584963 |
| 147 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.08965672 |
| 148 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.08740452 |
| 149 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.08717890 |
| 150 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.08531329 |
| 151 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08383287 |
| 152 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.07801081 |
| 153 | Long-term potentiation_Homo sapiens_hsa04720 | 0.07727986 |
| 154 | Tight junction_Homo sapiens_hsa04530 | 0.06999050 |
| 155 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.06933098 |
| 156 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.06137596 |
| 157 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.06081808 |
| 158 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.05461482 |
| 159 | Mineral absorption_Homo sapiens_hsa04978 | 0.04863703 |
| 160 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.04833560 |
| 161 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.04672766 |
| 162 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.04135490 |
| 163 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.03797954 |
| 164 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.03059005 |
| 165 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.02845456 |
| 166 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.02844422 |
| 167 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.02727150 |
| 168 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.02482400 |
| 169 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.02394350 |
| 170 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.01869743 |
| 171 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.01688310 |
| 172 | Taste transduction_Homo sapiens_hsa04742 | 0.00391826 |
| 173 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.00294427 |
| 174 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.00057341 |
| 175 | Notch signaling pathway_Homo sapiens_hsa04330 | -0.0133068 |
| 176 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0109211 |
| 177 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | -0.0081435 |
| 178 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0021579 |

